Skip to main content

XDx to Use Ingenuity Software to Better Understand Gene Expression Tied to Immunity

NEW YORK (GenomeWeb News) — XDx, a molecular diagnostics company specializing in the immune system, has licensed Ingenuity Systems’ software, Ingenuity said today.
The IPA 5.0 software is used to “model, analyze, and understand” biological and chemical systems, Ingenuity said.
XDx measures gene expression in patient blood to monitor the immune system. Ingenuity said the IPA 5.0 enables users to “apply filters to their data to determine whether a particular gene or protein is detectable in sentinel tissues or other bodily fluids. ...."
Tod Klingler, vice president of Informatics at XDx, said in a statement that the software “provides us with access to its extensive knowledge base of gene function information assembled from the scientific literature through easy-to-use tools that our researchers can use to rapidly evaluate candidate biomarkers. Specifically, IPA allows us to make sense of our gene expression data in the context of known immune system interactions and pathways."
Financial terms of the agreement were not released.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.